Lucentis for New Onset Neovascular Glaucoma [clinicaltrials:NCT00727038]
Lucentis for New Onset Neovascular Glaucoma [clinicaltrials:NCT00727038]
Bio2RDF identifier
NCT00727038
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00727038
identifiers.org URI
acronym [clinicaltrials_vocabulary:acronym]
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
arm group [clinicaltrials_vocabulary:arm-group]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
Neovascular glaucoma is ...... he treatment of this disease.
brief title [clinicaltrials_vocabulary:brief-title]
Lucentis for New Onset Neovascular Glaucoma
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
Hypothesis:
Intr ...... nt with laser or cryotherapy.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2008-07-29T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
is fda regulated [clinicaltrials_vocabulary:is-fda-regulated]
is section 801 [clinicaltrials_vocabulary:is-section-801]
keyword [clinicaltrials_vocabulary:keyword]
carotid stenosis
central retinal vein occlusion
neovascular glaucoma
neovascular
new onset glaucoma
ocular ischemic syndrome
proliferative diabetic retinopathy
retinal ischemia
vascular endothelial growth factor
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2010-07-26T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00727038
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
Randomized Controlled Trial of ...... New Onset Neovascular Glaucoma
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-07-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
Company withdrew funding/sponsorship
identifier
clinicaltrials:NCT00727038
title
Lucentis for New Onset Neovascular Glaucoma
@en
type
label
Lucentis for New Onset Neovascular Glaucoma [clinicaltrials:NCT00727038]
@en